Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer

Intern Med. 2017;56(14):1915-1918. doi: 10.2169/internalmedicine.56.8134. Epub 2017 Jul 15.

Abstract

We report the case of a 69-year-old woman with proximal limb muscle weakness, who received post-operative chemotherapy for uterine cancer. Her serum creatinine kinase level was high (10,779 mg/dL) and a muscle biopsy from her left biceps revealed various sizes of muscle fibers accompanied by necrotic and regenerating fibers. She was positive for anti-3 hydroxy-3-methylglutary-coenzyme A reductase (anti-HMGCR) antibodies, but negative for anti-signal recognition particle (anti-SRP) antibodies. She was diagnosed with immune-mediated necrotizing myopathy (IMNM) and treated with prednisolone. Our findings indicate that not only drug-induced myopathy but also paraneoplastic myopathy can be involved in the pathogenesis of IMNM.

Keywords: HMGCR; immune-mediated necrotizing myopathy; paraneoplastic syndrome; steroid therapy; uterine cancer.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Autoantibodies / blood
  • Autoimmune Diseases / complications*
  • Autoimmune Diseases / immunology
  • Biopsy
  • Female
  • Humans
  • Hydroxymethylglutaryl CoA Reductases / immunology
  • Muscle, Skeletal / pathology
  • Muscular Diseases / complications*
  • Muscular Diseases / immunology
  • Necrosis / pathology
  • Signal Recognition Particle / immunology
  • Uterine Neoplasms / complications*
  • Uterine Neoplasms / pathology

Substances

  • Autoantibodies
  • Signal Recognition Particle
  • Hydroxymethylglutaryl CoA Reductases